Daniella Zheleva

Years Active: 2020-2020
Publications (10 Years): 1

Cyclacel Ltd

University of Sofia, Saint Kliment Ochridski (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cyclacel Ltd Jun 01 1997

United Kingdom

Program leader/manager :: R&D

Education History

University of Sofia, Saint Kliment Ochridski Sep 05 1981 - May 24 1986

Bulgaria

BSC :: Biology

Publications

Sheelagh Frame, Chiara Saladino, Craig MacKay, Butrus Atrash, Peter Sheldrake, Edward McDonald, Paul Andrew Clarke, Paul Workman, David Blake, Daniella Zheleva
Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer. PloS one 15 (7) (2020)

Daniella Zheleva.css-eqlu8i{font-size:small;padding-left:4px;}